Diageo plc (NYSE:DEO) Logo Shufro Rose & Co Llc decreased its stake in Novartis A G (NVS) by 70.79% based on its latest 2019Q2 regulatory filing with the SEC. Shufro Rose & Co Llc sold 12,007 shares as the company’s stock rose 11.81% . The institutional investor held 4,955 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $452,000, down from 16,962 at the end of the previous reported quarter. Shufro Rose & Co Llc who had been investing in Novartis A G for a number of months, seems to be less bullish one the $197.26B market cap company. The stock decreased 2.79% or $2.5 during the last trading session, reaching $86.99. About 2.35 million shares traded or 23.59% up from the average. Novartis AG (NYSE:NVS) has risen 22.04% since September 14, 2018 and is uptrending. It has outperformed by 22.04% the S&P500. Some Historical NVS News: 14/05/2018 – Novartis’ tone-deaf response to Michael Cohen: troubling, but not surprising; 22/03/2018 – Phase lll data in The Lancet show Novartis siponimod significantly improved outcomes in patients with secondary progressive MS; 05/04/2018 – Biogen and Samsung Bioepis Agree to Settlement with AbbVie Allowing Commercialization of IMRALDI™ (Adalimumab Biosimilar) in; 30/05/2018 – Novartis Drug Promacta Gets FDA Priority Review for First-Line SAA; 05/04/2018 – Biogen and Samsung Bioepis Agree to Settlement With AbbVie Allowing Commercialization of IMRALDI(TM) (Adalimumab Biosimilar) in Europe; 16/05/2018 – Novartis’s Top Lawyer is Out After Payments to Michael Cohen; 17/04/2018 – Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures; 18/05/2018 – Novartis, Amgen: Aimovig Is First FDA Approved CGRP-R Drug; 27/03/2018 – $GSK to buy stake in consumer healthcare joint venture from $NVS for $13B after pulling out of $20B race for $PFE’s consumer health care unit; 27/03/2018 – Oncobiologics Appoints Dr. Joerg Windisch to Board of Directors
Cooke & Bieler Lp decreased its stake in Diageo Plc Adr (DEO) by 98.92% based on its latest 2019Q2 regulatory filing with the SEC. Cooke & Bieler Lp sold 238,370 shares as the company’s stock declined 0.17% . The institutional investor held 2,600 shares of the beverages (production and distribution) company at the end of 2019Q2, valued at $448,000, down from 240,970 at the end of the previous reported quarter. Cooke & Bieler Lp who had been investing in Diageo Plc Adr for a […]
